亿帆医药：亿立舒如有新的区域上市销售，公司将依规则及时披露

Group 1 - The core viewpoint of the article is that Yifan Pharmaceutical is committed to timely disclosure regarding the new regional sales of Yilishu and will communicate investor concerns about its overseas market performance to management [2] Group 2 - Yifan Pharmaceutical responded to investor inquiries on its interactive platform, indicating that it will follow regulations for any new regional market launches of Yilishu [2] - The company acknowledges the importance of investor feedback regarding the overseas market performance of Yilishu [2]